KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resmed (RMD) Amortization - Intangibles (2016 - 2025)

Historic Amortization - Intangibles for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to $11.8 million.

  • Resmed's Amortization - Intangibles rose 649.04% to $11.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $46.5 million, marking a year-over-year increase of 362.0%. This contributed to the annual value of $45.3 million for FY2025, which is 268.27% down from last year.
  • Latest data reveals that Resmed reported Amortization - Intangibles of $11.8 million as of Q4 2025, which was up 649.04% from $12.0 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Amortization - Intangibles ranged from a high of $12.5 million in Q3 2023 and a low of $6.4 million during Q2 2022
  • Moreover, its 5-year median value for Amortization - Intangibles was $11.2 million (2021), whereas its average is $11.0 million.
  • Its Amortization - Intangibles has fluctuated over the past 5 years, first tumbled by 4232.89% in 2022, then skyrocketed by 9311.8% in 2023.
  • Resmed's Amortization - Intangibles (Quarter) stood at $11.2 million in 2021, then fell by 14.85% to $9.6 million in 2022, then increased by 21.06% to $11.6 million in 2023, then dropped by 4.58% to $11.0 million in 2024, then rose by 6.49% to $11.8 million in 2025.
  • Its last three reported values are $11.8 million in Q4 2025, $12.0 million for Q3 2025, and $11.9 million during Q2 2025.